The global allergy immunotherapy market size is expected to reach around US$ 3.73 Bn by 2026 and is projected to expand at CAGR of 11.7% from 2019 to 2026.
The report analyzes and forecasts the allergy immunotherapy market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of allergy immunotherapy, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major allergy immunotherapy companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of allergy immunotherapy upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of allergy immunotherapy and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global allergy immunotherapy market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the allergy immunotherapy market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of allergy immunotherapy market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Major players operating in the global allergy immunotherapy market are Stallergenes Greer, Aimmune Therapeutics, ALK-Abello A/S, Allergy Therapeutics, Merck KGaA (Allergopharma), HAL Allergy Group, DBV Technologies, Circassia, Biomay AG, and Anergis.
The global allergy immunotherapy market has been segmented as follows:
By Treatment Type
By Allergy Type
By Distribution Channel
By Region
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
Allergy Immunotherapy Market Size, Share & Trends Analysis Report - By Region, And Segment Forecasts, 2020 - 2030
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Allergy Immunotherapy Market, By Treatment Type
7.1. Allergy Immunotherapy Market, By Treatment Type, 2020-2030
7.1.1. Subcutaneous Immunotherapy (SCIT)
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Sublingual Immunotherapy (SLIT)
7.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Allergy Immunotherapy Market, By Allergy Type
8.1. Allergy Immunotherapy Market, By Allergy Type, 2020-2030
8.1.1. Allergic Rhinitis
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Allergic Asthma
8.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Allergy Immunotherapy Market, By Distribution Channel
9.1. Allergy Immunotherapy Market, by Distribution Channel, 2020-2030
9.1.1. Hospital Pharmacy
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Retail Pharmacy
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Online Pharmacy
9.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Allergy Immunotherapy Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.1.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.1.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.1.4.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.1.4.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.1.5.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.1.5.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.2.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.2.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.2.4.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.2.4.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.2.5.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.2.5.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.2.6.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.2.6.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.2.7.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.2.7.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.3.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.3.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.3.4.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.3.4.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.3.5.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.3.5.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.3.6.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.3.6.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.3.7.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.3.7.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.4.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.4.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.4.4.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.4.4.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.4.5.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.4.5.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.4.6.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.4.6.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.4.7.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.4.7.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.5.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.5.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.5.4.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.5.4.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Treatment Type (2016-2030)
10.5.5.2. Market Revenue and Forecast, By Allergy Type (2016-2030)
10.5.5.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
Chapter 11. Company Profiles
11.1. ASIT Biotech
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Circassia
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Mylan N.V.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Adamis Pharmaceuticals Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Merck KGaA
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Stallergenes Greer plc
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Allergy Therapeutics
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. ALK-Abelló A/S
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. DESENTUM OY
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. HAL Allergy B.V.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. HollisterStier Allergy
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. LETIPharma
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. DBV Technologies SA
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers